PPMO pre-treatment is beneficial for AAV-based gene therapy in Duchenne Muscular Dystrophy - Neurophysiologie Respiratoire Expérimentale et Clinique Access content directly
Conference Poster Year :

Dates and versions

hal-03996969 , version 1 (15-03-2023)

Identifiers

  • HAL Id : hal-03996969 , version 1

Cite

Anne Forand, Antoine Muchir, Nathalie Mougenot, Caroline Sevoz-Couche, Cécile Peccate, et al.. PPMO pre-treatment is beneficial for AAV-based gene therapy in Duchenne Muscular Dystrophy. Myologie 2019, Mar 2019, Bordeaux, France. ⟨hal-03996969⟩
16 View
2 Download

Share

Gmail Facebook Twitter LinkedIn More